Skip to main content

Cyclophosphamide (International)

In the US, Cyclophosphamide (cyclophosphamide systemic) is a member of the drug class alkylating agents and is used to treat Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Cogan's Syndrome, Dermatomyositis, Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Ewing's Sarcoma, Granulomatosis with Polyangiitis, Histiocytosis, Hodgkin's Lymphoma, Lupus, Lupus Nephritis, Mantle Cell Lymphoma, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neuroblastoma, Non Small Cell Lung Cancer, Non-Hodgkin's Lymphoma, Organ Transplant - Rejection Prophylaxis, Osteosarcoma, Ovarian Cancer, Pemphigoid, Pemphigus, Primary Immunoglobulin A Nephropathy, Prostate Cancer, Rheumatoid Arthritis, Scleroderma, Small Cell Lung Cancer, Systemic Sclerosis, Testicular Cancer and Wilms' Tumor.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AA01

CAS registry number (Chemical Abstracts Service)

0000050-18-0

Chemical Formula

C7-H15-Cl2-N2-O2-P

Molecular Weight

261

Therapeutic Categories

Disease-modifying antirheumatic drug, DMARD

Cytostatic alkylating agent

Chemical Name

2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroetyl)tetrahydro-, 2-oxide

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs